Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Fluorodeoxyglucose F18”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableStudy completedNCT00907140
What this trial is testing

Fludeoxyglucose (FDG) Positron Emission Tomography/Computed Tomography (PET/CT) Cervical Heterogenity Imaging Study

Who this might be right for
Cervical Cancer
Washington University School of Medicine 25
Not applicableStudy completedNCT00282906
What this trial is testing

FDG Positron Emission Tomography and Computed Tomography (PET-CT) in Metastatic Prostate Cancer

Who this might be right for
Prostate Cancer
University of Southern California 257
Not applicableStudy completedNCT05569733
What this trial is testing

Simultaneous Fluorodeoxyglucose Positron Emission Tomography (PET) and Magnetic Resonance (MR) in Visual Snow Syndrome

Who this might be right for
Visual Snow Syndrome
Universitaire Ziekenhuizen KU Leuven 22
Not applicableLooking for participantsNCT06199713
What this trial is testing

Correlating Early FDG PET/CT and ctDNA in Immune Checkpoint Inhibitor (ICI)-Treated Melanoma Patients

Who this might be right for
MelanomaMelanoma Stage IIIMelanoma Stage IV+1 more
University of Wisconsin, Madison 24
Not applicableUnknownNCT03051568
What this trial is testing

Evaluating 18F-FDG PET/CT With Liver SUVmax-based Criteria for Prognosis of Patients With Peripheral T-cell Lymphoma

Who this might be right for
Lymphoma, T-Cell, Peripheral
Peking University Cancer Hospital & Institute 80
Not applicableStudy completedNCT05186610
What this trial is testing

FDG PET/CT and Directed Metabolic Core Needle Biopsy in the Management of Lymphoma

Who this might be right for
Lymphoma
Post Graduate Institute of Medical Education and Research, Chandigarh 480
Not applicableStudy completedNCT04391348
What this trial is testing

Combination PET With 18F-fluorodeoxyglucose (18F-FDG) and 18 F-choline in Patient With HCC

Who this might be right for
Hepatocellular Carcinoma
Assistance Publique - Hôpitaux de Paris 230
Testing effectiveness (Phase 2)Study completedNCT00559377
What this trial is testing

FDG and FMISO PET Hypoxia Evaluation in Cervical Cancer

Who this might be right for
Cervical AdenocarcinomaCervical Squamous Cell CarcinomaStage IB Cervical Cancer+5 more
National Cancer Institute (NCI) 16
Not applicableEnded earlyNCT02204202
What this trial is testing

PET Assessment of Acute Lung Transplant Rejection

Who this might be right for
Lung Disease
Washington University School of Medicine 28
Not applicableStudy completedNCT02043002
What this trial is testing

Early Changes in Positron Emissions Tomography (PET/CT) Scan as Predictors of Clinical Outcome in NSCLC Treated With EGFR Tyrosin Kinase Inhibitors (TKI)

Who this might be right for
Non-small Cell Lung Cancer Patients
University of Aarhus 67
Early research (Phase 1)Study completedNCT03195270
What this trial is testing

Use of PET/MR Imaging in Chronic Pain

Who this might be right for
Chronic Pain
Stanford University 88
Not applicableStudy completedNCT02300402
What this trial is testing

Detection and Characterization of Residual Masses in Lymphomas

Who this might be right for
Hodgkin LymphomaB-Cell Lymphoma
The Lymphoma Academic Research Organisation 120
Not applicableStudy completedNCT00958087
What this trial is testing

Cardiac Sarcoidosis and FDG-PET

Who this might be right for
SarcoidosisDilated Cardiomyopathy
Kurume University 20
Large-scale testing (Phase 3)Study completedNCT00002930
What this trial is testing

PET Scan in Patients With Lung and Esophageal Cancers That May Be Removed by Surgery

Who this might be right for
Esophageal CancerLung Cancer
Memorial Sloan Kettering Cancer Center 75
Not applicableStudy completedNCT01021514
What this trial is testing

Association Between Arterial Wall Uptake of Fluorodeoxyglucose on PET Imaging and sRAGE

Who this might be right for
sRAGE LevelSUV and TBR Levels in FDG PET
Korea University 82
Testing effectiveness (Phase 2)Ended earlyNCT00123786
What this trial is testing

Study of 18F-Fluorodeoxyglucose (FluGlucoScan) in Patients With Known or Suspected Soft Tissue Sarcoma

Who this might be right for
Sarcoma
AHS Cancer Control Alberta 4
Testing effectiveness (Phase 2)UnknownNCT00254683
What this trial is testing

Use of Positron Emission Tomography/Computed Tomography (PET/CT) to Assess Tumor Response to Neoadjuvant Treatment for Distal Rectal Cancer

Who this might be right for
Rectal Cancer
University of Sao Paulo 100
Not applicableEnded earlyNCT02608528
What this trial is testing

Serial [18F]Fluorodeoxyglucose ([18F]FDG )PET/CT as a Biomarker of Therapeutic Response in Anti-PD1/PDL1 Therapy

Who this might be right for
Non-Small Cell Lung Cancer (NSCLC)
Abramson Cancer Center at Penn Medicine 10
Not applicableUnknownNCT05912465
What this trial is testing

Predicting Lung Cancer-Associated Cachexia With PET Imaging

Who this might be right for
CachexiaLung Neoplasm
Medical University of Vienna 150
Early research (Phase 1)Study completedNCT00703261
What this trial is testing

Evaluate the Utility of 18FDG-PET as a Tool to Quantify Atherosclerotic Plaque (MK-0000-081 AM3)(COMPLETED)

Who this might be right for
Atherosclerotic Vascular Disease
Merck Sharp & Dohme LLC 83
Next Page